The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial

BACKGROUND: This study aimed to investigate the medroxyprogesterone acetate (MPA) + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who received in vitro fertilization (IVF). METHODS: Three hundred patients with advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Haiyan, Du, Tong, Gao, Hongyuan, Xi, Qianwen, Wu, Ling, Lyu, Qifeng, Zhu, Qianqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531409/
https://www.ncbi.nlm.nih.gov/pubmed/36195878
http://dx.doi.org/10.1186/s12978-022-01500-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531409/
https://www.ncbi.nlm.nih.gov/pubmed/36195878
http://dx.doi.org/10.1186/s12978-022-01500-z

Ejemplares similares